Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis

Journal of the American College of Cardiology

Volumn 60, Issue 18, 2012, Pages 1739-1742

  Stabile, Eugenio ^a   Virga, Vittorio ^a   Salemme, Luigi ^a   Cioppa, Angelo ^a   Ambrosini, Vittorio ^a   Sorropago, Giovanni ^a   Tesorio, Tullio ^a   Cota, Linda ^a   Popusoi, Grigore ^a   Pucciarelli, Armando ^a   Biamino, Giancarlo ^a   Rubino, Paolo ^a  

^a Clinica Montevergine   (Italy)

Author keywords

drug eluting balloon(s); in stent restenosis; superficial femoral artery

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; NITINOL; TICLOPIDINE;

AGED; ARTICLE; CEREBROVASCULAR DISEASE; CLAUDICATION; CLINICAL ARTICLE; CORONARY STENT; DRUG ELUTING STENT; ECHOGRAPHY; FEMALE; HEART DISEASE; HEART FAILURE; HUMAN; IN-STENT RESTENOSIS; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF EXPANDING STENT; SUPERFICIAL FEMORAL ARTERY; VASCULAR PATENCY;

AGED; ALLOYS; ANGIOPLASTY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; STENTS; TREATMENT OUTCOME; VASCULAR DISEASES; VASCULAR PATENCY;

EID: 84867889255     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.07.033     Document Type: Article

References (14)

1. V.L. Rowe, W. Lee, F.A. Weaver, D. Etzioni Patterns of treatment for peripheral arterial disease in the United States: 1996-2005 J Vasc Surg 49 2009 910 917
2. Y. Soga, O. Iida, K. Hirano, H. Yokoi, S. Nanto, M. Nobuyoshi Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent J Vasc Surg 52 2010 608 615
3. M. Schillinger, S. Sabeti, C. Loewe Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery N Engl J Med 354 2006 1879 1888
4. J.R. Laird, B.T. Katzen, D. Scheinert Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial Circ Cardiovasc Interv 3 2010 267 276
5. A. Tosaka, Y. Soga, O. Iida Classification and clinical impact of restenosis after femoropopliteal stenting J Am Coll Cardiol 59 2012 16 23
6. G. Tepe, T. Zeller, T. Albrecht Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
7. A. Micari, A. Cioppa, G. Vadalà A new paclitaxel-eluting balloon for angioplasty of femoropopliteal obstructions: acute and midterm results EuroIntervention 7 Suppl K 2011 K77 K82
8. B. Scheller, C. Hehrlein, W. Bocksch Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124
9. D. Scheinert, S. Scheinert, J. Sax Prevalence and clinical impact of stent fractures after femoropopliteal stenting J Am Coll Cardiol 45 2005 312 315
10. P. Dick, S. Sabeti, W. Mlekusch Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience Radiology 248 2008 297 302
11. T. Zeller, A. Rastan, S. Sixt Long-term results after directional atherectomy of femoro-popliteal lesions J Am Coll Cardiol 48 2006 1573 1578
12. K.K. Yeo, U. Malik, J.R. Laird Outcomes following treatment of femoropopliteal in-stent restenosis: a single center experience Catheter Cardiovasc Interv 78 2011 604 608
13. M.D. Dake, D. Scheinert, G. Tepe Zilver PTX Single-Arm Study Investigators Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study J Endovasc Ther 18 2011 613 623
14. J.R. Laird, K.K. Yeo The treatment of femoropopliteal in-stent restenosis: back to the future J Am Coll Cardiol 59 2012 24 25